Maria Alice Franzoi1,2, Gilberto Schwartsmann3, Sérgio Jobim de Azevedo3, Guilherme Geib3, Facundo Zaffaroni4,5, Pedro E R Liedke3,4. 1. Department of Oncology, Hospital de Clínicas de Porto Alegre, Ramiro Barcelos, 2350, Porto Alegre, RS, 90035-903, Brazil. franzoi.alice@gmail.com. 2. Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil. franzoi.alice@gmail.com. 3. Department of Oncology, Hospital de Clínicas de Porto Alegre, Ramiro Barcelos, 2350, Porto Alegre, RS, 90035-903, Brazil. 4. Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil. 5. FARO STAT SOLUTIONS, Porto Alegre, Brazil.
Abstract
PURPOSE: Describe the clinical and epidemiological data from young women with breast cancer and determine the association between ethnicity, insurance status, family income, and breast cancer stage at the diagnosis in this population. METHODS: Women under the age of 40 diagnosed with invasive breast cancer from 2010 to 2014 and identified in the Surveillance, Epidemiology, and End Results (SEER) 18 registries database were included. Binary logistic regression was applied in order to estimate the odds ratios (ORs) for factors that were potentially predictive for receiving a breast cancer diagnosis at stage I. RESULTS: Of 14,379 young women with invasive breast cancer, 70.9% of the patients were white, 15.9% black, and 13.2% classified as other ethnicity (American Indian, Asian, Pacific Islander). The initial clinical stage at diagnosis was stage I in 28.2%, II in 45.2%, III in 19.0%, and IV in 7.6%. The chi-square test showed a significant association between clinical stage at diagnosis and family income (p < 0.0001), insurance status (p < 0.0001), and ethnicity (p < 0.0001). The ORs for being diagnosed at stage I, regarding different factors, revealed that women with family income higher than US$ 85,000 were more likely to be diagnosed with stage I (OR [95%CI], 1.306 [1.173-1.454]; p value < 0.0001) when compared with patients with family income of less than US$ 60,000. Black women were less likely to be diagnosed with stage I (OR [95%CI], 0.676 [0.605-0.755]; p value < 0.0001), when compared with white women. Uninsured women were less likely to be diagnosed with stage I (OR [95%CI], 0.586 [0.529-0.648]; p value < 0.0001) when compared with women with insurance coverage. CONCLUSION: Among young US women diagnosed with invasive breast cancer, most of them presented early stage disease. Women with black ethnicity, low income, and uninsured are at risk for late-stage presentation. Improvements in strategies to allow earlier breast cancer diagnosis in these at risk population are urged.
PURPOSE: Describe the clinical and epidemiological data from young women with breast cancer and determine the association between ethnicity, insurance status, family income, and breast cancer stage at the diagnosis in this population. METHODS:Women under the age of 40 diagnosed with invasive breast cancer from 2010 to 2014 and identified in the Surveillance, Epidemiology, and End Results (SEER) 18 registries database were included. Binary logistic regression was applied in order to estimate the odds ratios (ORs) for factors that were potentially predictive for receiving a breast cancer diagnosis at stage I. RESULTS: Of 14,379 young women with invasive breast cancer, 70.9% of the patients were white, 15.9% black, and 13.2% classified as other ethnicity (American Indian, Asian, Pacific Islander). The initial clinical stage at diagnosis was stage I in 28.2%, II in 45.2%, III in 19.0%, and IV in 7.6%. The chi-square test showed a significant association between clinical stage at diagnosis and family income (p < 0.0001), insurance status (p < 0.0001), and ethnicity (p < 0.0001). The ORs for being diagnosed at stage I, regarding different factors, revealed that women with family income higher than US$ 85,000 were more likely to be diagnosed with stage I (OR [95%CI], 1.306 [1.173-1.454]; p value < 0.0001) when compared with patients with family income of less than US$ 60,000. Black women were less likely to be diagnosed with stage I (OR [95%CI], 0.676 [0.605-0.755]; p value < 0.0001), when compared with white women. Uninsured women were less likely to be diagnosed with stage I (OR [95%CI], 0.586 [0.529-0.648]; p value < 0.0001) when compared with women with insurance coverage. CONCLUSION: Among young US women diagnosed with invasive breast cancer, most of them presented early stage disease. Women with black ethnicity, low income, and uninsured are at risk for late-stage presentation. Improvements in strategies to allow earlier breast cancer diagnosis in these at risk population are urged.
Entities:
Keywords:
Breast cancer staging; Ethnic disparities; Socioeconomic disparities
Authors: Rachel A Freedman; Melissa E Hughes; Rebecca A Ottesen; Jane C Weeks; Yulei He; Yu-Ning Wong; Richard Theriault; Nancy L Keating Journal: Cancer Date: 2012-09-25 Impact factor: 6.860
Authors: Robert C Millikan; Beth Newman; Chiu-Kit Tse; Patricia G Moorman; Kathleen Conway; Lynn G Dressler; Lisa V Smith; Miriam H Labbok; Joseph Geradts; Jeannette T Bensen; Susan Jackson; Sarah Nyante; Chad Livasy; Lisa Carey; H Shelton Earp; Charles M Perou Journal: Breast Cancer Res Treat Date: 2007-06-20 Impact factor: 4.872
Authors: David E Nelson; Dwayne W Jarman; Jürgen Rehm; Thomas K Greenfield; Grégoire Rey; William C Kerr; Paige Miller; Kevin D Shield; Yu Ye; Timothy S Naimi Journal: Am J Public Health Date: 2013-02-14 Impact factor: 9.308
Authors: Juan J Grau; Gabriel Zanon; Carlos Caso; Xavier Gonzalez; Araceli Rodriguez; Miguel Caballero; Albert Biete Journal: Ann Surg Oncol Date: 2013-06-11 Impact factor: 5.344
Authors: Kristen E Rhodin; Cierra S Hong; Lindsey A Olivere; Elizabeth P Howell; Vinay K Giri; Kurren A Mehta; Taofik Oyekunle; Randall P Scheri; Betty C Tong; Julie A Sosa; Oluwadamilola M Fayanju Journal: J Surg Res Date: 2020-05-04 Impact factor: 2.192
Authors: Alice Yunzi L Yu; Samantha M Thomas; Gayle D DiLalla; Rachel A Greenup; E Shelley Hwang; Terry Hyslop; Carolyn S Menendez; Jennifer K Plichta; Lisa A Tolnitch; Oluwadamilola M Fayanju Journal: Cancer Date: 2021-11-18 Impact factor: 6.860
Authors: Joseph M Unger; Charles D Blanke; Michael LeBlanc; William E Barlow; Riha Vaidya; Scott D Ramsey; Dawn L Hershman Journal: JAMA Netw Open Date: 2020-04-01